definiens: shall mean such Arising Intellectual Property that ( a ) is conceived and/or reduced to practice inthe course of, or as a result of, performance of the Research and CMC Plan and associated Work Orders ; and ( b ) relates specifically toany of the following:(i ) a Collaboration Candidate, CAR - NK Cell expressing a CAR containing an Antibody Binder directed to a Collaboration Target, or a CAR structure containing an Antibody Binder directed to a Collaboration Target, including compositions, methods of use orprocesses of manufacture that are specific to the manufacture or use of any such Collaboration Candidate, CAR - NK Cell, or CARstructure, as applicable;(ii ) Antibody Binders ( including compositions, methods of use, or processes of manufacture of an Antibody Binder ) ; or(iii ) any other Arising Intellectual Property that is not Arising GCLC Core IP